APP and Alzheimer disease: Human APP proteolytic cleavage occurs via two alternative pathways: amyloidogenic and non-amyloidogenic, resulting in a peptide of 37 to 49 amino acids known as Aβ, which is a primary component of amyloid plaques in the brains of AD patients [20].